PLXNB1/SEMA4D signals mediate interactions between malignant epithelial and immune cells to promote colorectal cancer liver metastasis
View abstract on PubMed
Summary
This summary is machine-generated.Colorectal cancer liver metastases involve specific epithelial cell subtypes (Epi-11) interacting with immune cells. This crosstalk, mediated by the PLXNB1/SEMA4D axis, impacts patient prognosis and cancer cell behavior.
Area Of Science
- Oncology
- Immunology
- Genomics
Background
- Colorectal cancer (CRC) liver metastases (LM) arise from complex interactions between tumor cells and their microenvironment.
- Understanding cellular heterogeneity in primary CRC and LM is crucial for identifying drivers of metastasis.
Purpose Of The Study
- To characterize cellular heterogeneity in CRC and LM using single-cell sequencing.
- To identify intercellular communication pathways between epithelial and immune cells in CRC and LM.
- To develop a prognostic model based on metastatic epithelial cell gene expression.
Main Methods
- Integrated single-cell sequencing data analysis.
- Construction of a prognostic model using gene expression data.
- Multiplex immunofluorescence staining.
- In vitro assays (wound healing, migration, apoptosis).
Main Results
- Identified approximately 17 epithelial cell subtypes, with Epi-11 cells highly expressed in LM.
- High expression of the Epi-11 metastasis-related genetic profile correlated with poorer prognosis.
- Epi-11 cells showed increased interaction with myeloid and T/NK cells in LM via the PLXNB1/SEMA4D axis.
- High SEMA4D expression correlated with decreased overall survival in CRC patients.
- SEMA4D knockdown inhibited cell migration and promoted apoptosis in vitro.
Conclusions
- Epi-11 cells represent a key epithelial subset driving CRC liver metastasis.
- The PLXNB1/SEMA4D signaling axis mediates crosstalk between Epi-11 cells and immune cells.
- Targeting this axis may offer therapeutic strategies for colorectal cancer liver metastasis.

